Navigation Links
Inverness Medical Innovations Launches New FDA Cleared C. DIFF QUIK CHEK COMPLETE(TM) Rapid Test
Date:3/30/2009

WALTHAM, Mass., March 30 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will begin marketing and distributing the new C. DIFF QUIK CHEK COMPLETE(TM) rapid test as an in vitro diagnostic aid for Clostridium difficile associated disease (CDAD). This follows TECHLAB(R), Inc.'s recent clearance from the Federal Drug Administration (FDA) to manufacture the product for Inverness. C. difficile is responsible for the most common form of hospital-acquired diarrhea and antibiotic-associated colitis. C. difficile is highly infectious and a significant danger to the health of immunocompromised or elderly patients. The infection can be life-threatening when not caught in time to allow for appropriate therapy to combat the disease and thereby reduce morbidity associated with CDAD. The new rapid test yields results within 30 minutes and detects all strains of C. difficile, including the highly virulent strain BINAP1/027 which is causing outbreaks of increasing severity and mortality across Europe and North America. Collective scientific data suggests that the incidence of C. difficile infection (CDI) has recently increased in East Asia and the Middle East, further highlighting the disease as a global epidemic. In US Hospitals alone, current annual spending is estimated at $40 million in testing aimed at diagnosing CDAD patients in order to provide appropriate therapy and control the spread of the disease.

While primarily a hospital-acquired disease, C. difficile infection is increasingly occurring in community outpatient settings. This is causing a major problem for hospital and community care environments because th
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Inverness Medical Innovations to Pay April Series B Dividend in Additional Shares of Series B Stock
2. Inverness Medical Innovations Agrees to Acquire Second Territory Rapid Diagnostics Business of ACON
3. Inverness Medical Innovations Announces Fourth Quarter 2008 Results
4. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 18, 2009 to Discuss Fourth Quarter 2008 Results
5. James Roosevelt, Jr. Joins Inverness Medical Innovations Board of Directors
6. Inverness Medical Innovations to Present at the 2009 UBS Global Healthcare Services Conference on February 10, 2009
7. Inverness Medical Innovations Presents the pima(TM) Point-of-Care CD4 Instrument at ICASA 2008
8. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 13, 2009
9. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
10. Inverness Medical Innovations to Present at RBC Capital Markets 2008 Healthcare Conference on December 11, 2008
11. Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO(TM) Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... The report “Nintedanib (Colorectal Cancer) – ... the current treatment landscape, unmet needs, current pipeline ... Stivarga is a drug which is used in ... Ingelheim is developing nintedanib (BIBF-1120), an orally available ... in the US, Europe, and Japan. The drug ...
(Date:12/25/2014)... Dylan Queen, a famous online company supplying women’s special ... prom dresses, most of which are priced under $200. ... the promotion is valid until Jan. 22, 2015; the ... market. , The prom dresses in this new collection ... strapless, empire strapless chiffon, one shoulder, floor-length, V-neck beading, ...
(Date:12/25/2014)... FL (PRWEB) December 25, 2014 When head ... find themselves in a frenzy to get rid of it ... But families in Coral Gables now have the solution right ... second salon clinic location, Lice Troopers provides full spectrum head ... the Coral Gable area, including Sunset, Key Biscayne, Brickell, Coconut ...
(Date:12/25/2014)... -- Among early stage breast cancer patients who undergo ... percent will eventually develop leukemia as a result of ... comes from a review of more than 20,000 breast ... suggests that the risk for developing treatment-related leukemia, though ... "The frequency of bone marrow cancers such as ...
(Date:12/25/2014)... 25, 2014 Plugin creators from Pixel ... A fully customizable business presentation tool made specifically for ... ProFire 5k business tool, users can now display their ... of Pixel Film Studios. “ProFire 5k gives users a ... add professionalism to a presentation” , Pixel Film Studios ...
Breaking Medicine News(10 mins):Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2
... of biology in the School of Science at Indiana ... eye and vision research organization in the world for ... blindness caused by macular degeneration, retinitis pigmentosa and other ... Research in Vision and Ophthalmology (ARVO) will present Meyer ...
... researchers have shown for the first time how peppermint ... to 20% of the population. In a paper ... , researchers from the University,s Nerve-Gut Research Laboratory explain ... soothing inflammatory pain in the gastrointestinal tract. Dr ...
... shows how inflammation can help cause cancer. Chronic inflammation ... inflammatory bowel disease is associated with up to 25 ... the Ohio State University Comprehensive Cancer Center Arthur ... Institute (OSUCCC James) found that inflammation stimulates a ...
... more effective than cutting calories for individuals who want to ... UT Southwestern Medical Center researchers. "What this study tells ... to reduce the amount of fat in your liver, you ... assistant professor of internal medicine at UT Southwestern and the ...
... , MONDAY, April 18 (HealthDay News) -- Patients with do-not-resuscitate ... after surgery, even after non-emergency procedures, a new study finds. ... used to revive someone who is clinically unresponsive and lacks ... and in the August print issue of the journal ...
... , MONDAY, April 18 (HealthDay News) -- Infection ... of many college students -- and little exposure to sunlight ... sclerosis, a new study suggests. "MS is more common ... lead researcher, Dr. George C. Ebers, of the University of ...
Cached Medicine News:Health News:IUPUI faculty member to receive national innovative vision research award 2Health News:Peppermint earns respect in mainstream medicine 2Health News:Study shows how inflammation can lead to cancer 2Health News:Limiting carbs, not calories, reduces liver fat faster, UT Southwestern researchers find 2Health News:People With DNR Orders More Apt to Die After Any Surgery 2Health News:Can Common Virus, Lack of Sunlight Boost MS Risk? 2
(Date:12/24/2014)... LONDON , December 24, 2014 /PRNewswire/ ... expected to grow at an average rate of 8.1%. ... and volume. Hip, knee and spine surgeries are the ... emerging economies they have a lower penetration. Increased number ... use of composites. Non-metallic orthopedic devices have gained popularity ...
(Date:12/24/2014)... Dec. 23, 2014  Advanced Medical Isotope Corporation ... primarily in the development of brachytherapy devices and ... announced that it has filed a de ... Administration ("FDA") for marketing clearance for its patented ... the U.S. Food, Drug and Cosmetic Act (the ...
(Date:12/24/2014)... , Dec. 23, 2014   Synageva BioPharma ... biopharmaceutical company developing therapeutic products for rare disorders, ... (EMA) of the Marketing Authorization Application (MAA) for ... granted the company,s request for accelerated assessment, which ... review time.   The MAA, and ...
Breaking Medicine Technology:Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3
... , GREENVILLE, S.C. , ... provide an online, real-time webcast and rebroadcast of its conference ... for the first quarter of fiscal 2010, which will be released ... The live broadcast of Span-America,s conference call will be available ...
... , , ... ERES ), a leading provider of centralized services to the ... ERT Knowledge Series of educational papers, written by ERT experts. ... trials today and further establishes ERT as an experienced and ...
Cached Medicine Technology:Span-America Announces First Quarter Conference Call On The Internet 2ERT Demonstrates Patient Safety Expertise in Clinical Trials with New Knowledge Series of Papers 2ERT Demonstrates Patient Safety Expertise in Clinical Trials with New Knowledge Series of Papers 3ERT Demonstrates Patient Safety Expertise in Clinical Trials with New Knowledge Series of Papers 4ERT Demonstrates Patient Safety Expertise in Clinical Trials with New Knowledge Series of Papers 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: